Health
Pfizer, BioNTech to supply 120 million doses of coronavirus vaccine to Japan – Reuters India
Pfizer Inc and BioNTech SE have agreed to supply Japan with 120 million doses of their experimental coronavirus vaccine in the first half of 2021, the companies said on Friday.
(Reuters) – Pfizer Inc (PFE.N) and BioNTech SE (BNTX.O) have agreed to supply Japan with 120 million doses of their experimental coronavirus vaccine in the first half of 2021, the companies said on Friday.
The companies did not disclose the financial details of the agreement, but said terms were based on the volume of doses and the timing of the delivery.
The United States has signed a similar deal with Pfizer and BioNtech for 100 million doses for nearly $2 billion, which amounts to a $39 p…
-
Noosa News23 hours agoFuel tanker driver killed in horror head-on crash near Blackbutt identified as beloved father-of-two
-
General17 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Noosa News21 hours agoPalestine protesters forced into last-minute reroute
-
Business21 hours agoUp 20% in 2 days, are Codan shares a buy, hold or sell?